• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.

作者信息

Van Kernebeek M W, Ghesquiere M, Vanderbruggen N, Verhoeven E, Hubloue I, Crunelle C L

机构信息

Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Department of Emergency Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

出版信息

Clin Toxicol (Phila). 2021 May;59(5):447-448. doi: 10.1080/15563650.2020.1818768. Epub 2020 Sep 22.

DOI:10.1080/15563650.2020.1818768
PMID:32960128
Abstract
摘要

相似文献

1
Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.卡巴拉汀用于治疗严重苯海索中毒后的抗胆碱能谵妄。
Clin Toxicol (Phila). 2021 May;59(5):447-448. doi: 10.1080/15563650.2020.1818768. Epub 2020 Sep 22.
2
Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.关于使用卡巴拉汀治疗严重丙环定中毒后抗胆碱能谵妄的回复信
Clin Toxicol (Phila). 2021 Sep;59(9):855-856. doi: 10.1080/15563650.2020.1869757. Epub 2021 Feb 12.
3
Treatment of Anticholinergic Delirium with Oral Rivastigmine: A Case Report.口服利斯的明治疗抗胆碱能谵妄:病例报告。
J Emerg Med. 2024 May;66(5):e589-e591. doi: 10.1016/j.jemermed.2024.03.017. Epub 2024 Mar 16.
4
Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.使用胆碱酯酶抑制剂成功治疗非抗胆碱能性谵妄。
J Clin Psychopharmacol. 2001 Feb;21(1):118. doi: 10.1097/00004714-200102000-00026.
5
Rivastigmine for the management of anticholinergic delirium.利斯的明治疗抗胆碱能谵妄。
Clin Toxicol (Phila). 2024 Feb;62(2):82-87. doi: 10.1080/15563650.2024.2319854. Epub 2024 Mar 11.
6
Rivastigmine Use in the Treatment of Antimuscarinic Delirium.卡巴拉汀用于抗胆碱能谵妄的治疗
J Med Toxicol. 2023 Jul;19(3):284-287. doi: 10.1007/s13181-023-00947-1. Epub 2023 May 19.
7
Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.口服及透皮型利斯的明治疗抗胆碱能谵妄:病例报告
J Emerg Med. 2023 Oct;65(4):e366-e368. doi: 10.1016/j.jemermed.2023.06.008. Epub 2023 Jun 20.
8
Donepezil for anticholinergic drug intoxication: a case report.多奈哌齐用于抗胆碱能药物中毒:一例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):885-7. doi: 10.1016/s0278-5846(03)00119-2.
9
Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.抗胆碱能负担对新诊断为痴呆症患者开始使用胆碱酯酶抑制剂后治疗改变、谵妄和死亡率的影响:一项基于人群的研究。
Basic Clin Pharmacol Toxicol. 2019 Jun;124(6):741-748. doi: 10.1111/bcpt.13184. Epub 2019 Jan 10.
10
Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium.
J Clin Psychopharmacol. 2022;42(3):329-331. doi: 10.1097/JCP.0000000000001533. Epub 2022 Mar 9.

引用本文的文献

1
Just the facts: rivastigmine for the management of anticholinergic toxicity.事实就是如此:卡巴拉汀用于抗胆碱能毒性的管理。
CJEM. 2025 Jul 14. doi: 10.1007/s43678-025-00952-z.
2
Treatment of pediatric antimuscarinic delirium with oral rivastigmine.口服卡巴拉汀治疗小儿抗胆碱能谵妄
Oxf Med Case Reports. 2023 Sep 25;2023(9):omad096. doi: 10.1093/omcr/omad096. eCollection 2023 Sep.
3
Rivastigmine Use in the Treatment of Antimuscarinic Delirium.卡巴拉汀用于抗胆碱能谵妄的治疗
J Med Toxicol. 2023 Jul;19(3):284-287. doi: 10.1007/s13181-023-00947-1. Epub 2023 May 19.
4
Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.苯海拉明引起的抗毒蕈碱谵妄用毒扁豆碱和透皮利斯的明治疗。
J Med Toxicol. 2023 Apr;19(2):219-223. doi: 10.1007/s13181-022-00925-z. Epub 2022 Dec 27.
5
Case series profile of olanzapine post-injection delirium/sedation syndrome.奥氮平注射后谵妄/镇静综合征的病例系列特征。
Br J Clin Pharmacol. 2023 Feb;89(2):903-907. doi: 10.1111/bcp.15588. Epub 2022 Nov 20.